CCCC logo

C4 Therapeutics (CCCC) Cash From Financing

Annual CFF

$45.34 M
-$153.00 K-0.34%

December 1, 2024


Summary


Performance

CCCC Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCCCCcash flowmetrics:

Quarterly CFF

$112.00 K
-$10.39 M-98.93%

December 31, 2024


Summary


Performance

CCCC Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCCCCcash flowmetrics:

TTM CFF

$45.34 M
-$57.56 M-55.94%

December 31, 2024


Summary


Performance

CCCC TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherCCCCcash flowmetrics:

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

CCCC Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-0.3%-98.9%-55.9%
3 y3 years-73.5%-98.9%-55.9%
5 y5 years+10000.0%-98.9%-55.9%

CCCC Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-73.5%+3852.6%-99.8%+101.0%-73.7%+473.6%
5 y5-year-87.0%>+9999.0%-99.9%+101.0%-87.6%+473.6%
alltimeall time-87.0%>+9999.0%-99.9%+101.0%-87.6%+473.6%

C4 Therapeutics Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2024
-
$112.00 K(-98.9%)
$45.34 M(-55.9%)
Dec 2024
$45.34 M(-0.3%)
-
-
Sep 2024
-
$10.51 M(+7682.2%)
$102.90 M(+26.0%)
Jun 2024
-
$135.00 K(-99.6%)
$81.64 M(+1.1%)
Mar 2024
-
$34.58 M(-40.0%)
$80.76 M(+77.5%)
Dec 2023
$45.49 M(+3865.9%)
$57.67 M(-636.3%)
$45.49 M(-474.8%)
Sep 2023
-
-$10.75 M(+1341.4%)
-$12.14 M(+1087.5%)
Jun 2023
-
-$746.00 K(+9.1%)
-$1.02 M(+5911.8%)
Mar 2023
-
-$684.00 K(-1555.3%)
-$17.00 K(-101.5%)
Dec 2022
$1.15 M
$47.00 K(-87.0%)
$1.15 M(-26.8%)
Sep 2022
-
$361.00 K(+39.4%)
$1.57 M(-12.5%)
DateAnnualQuarterlyTTM
Jun 2022
-
$259.00 K(-46.0%)
$1.79 M(-99.0%)
Mar 2022
-
$480.00 K(+3.0%)
$172.03 M(+0.4%)
Dec 2021
$171.40 M(-50.9%)
$466.00 K(-20.2%)
$171.40 M(-53.0%)
Sep 2021
-
$584.00 K(-99.7%)
$364.99 M(-0.5%)
Jun 2021
-
$170.50 M(<-9900.0%)
$366.90 M(+5.2%)
Mar 2021
-
-$151.00 K(-100.1%)
$348.63 M(-0.1%)
Dec 2020
$348.93 M(>+9900.0%)
$194.05 M(+7665.2%)
$348.93 M(+125.3%)
Sep 2020
-
$2.50 M(-98.4%)
$154.88 M(+1.6%)
Jun 2020
-
$152.22 M(>+9900.0%)
$152.38 M(>+9900.0%)
Mar 2020
-
$156.00 K
$156.00 K
Dec 2019
$244.00 K(-87.6%)
-
-
Dec 2018
$1.96 M
-
-

FAQ

  • What is C4 Therapeutics annual cash flow from financing activities?
  • What is the all time high annual CFF for C4 Therapeutics?
  • What is C4 Therapeutics annual CFF year-on-year change?
  • What is C4 Therapeutics quarterly cash flow from financing activities?
  • What is the all time high quarterly CFF for C4 Therapeutics?
  • What is C4 Therapeutics quarterly CFF year-on-year change?
  • What is C4 Therapeutics TTM cash flow from financing activities?
  • What is the all time high TTM CFF for C4 Therapeutics?
  • What is C4 Therapeutics TTM CFF year-on-year change?

What is C4 Therapeutics annual cash flow from financing activities?

The current annual CFF of CCCC is $45.34 M

What is the all time high annual CFF for C4 Therapeutics?

C4 Therapeutics all-time high annual cash flow from financing activities is $348.93 M

What is C4 Therapeutics annual CFF year-on-year change?

Over the past year, CCCC annual cash flow from financing activities has changed by -$153.00 K (-0.34%)

What is C4 Therapeutics quarterly cash flow from financing activities?

The current quarterly CFF of CCCC is $112.00 K

What is the all time high quarterly CFF for C4 Therapeutics?

C4 Therapeutics all-time high quarterly cash flow from financing activities is $194.05 M

What is C4 Therapeutics quarterly CFF year-on-year change?

Over the past year, CCCC quarterly cash flow from financing activities has changed by -$10.39 M (-98.93%)

What is C4 Therapeutics TTM cash flow from financing activities?

The current TTM CFF of CCCC is $45.34 M

What is the all time high TTM CFF for C4 Therapeutics?

C4 Therapeutics all-time high TTM cash flow from financing activities is $366.90 M

What is C4 Therapeutics TTM CFF year-on-year change?

Over the past year, CCCC TTM cash flow from financing activities has changed by -$57.56 M (-55.94%)